Scientists have early evidence that one way to kill recurring cancer cells may be with a lot of iron. More here
We publish several newsletters throughout the year. These provide the latest news and information about the Prospect group and PCa in general.Â The Summer ’23 newsletter is downloadable via this link (click link or right click and save as…). This issue of the newsletter has news about our summer meetings, the botanic garden tour and the docks walk. There is also an article on psychological approaches in recovery. David Casley, Prospect Publicity 07860 369064;Â EmailÂ email@example.com
Scientists discover a new molecule that kills even the deadliest cancer, but no mention of PCa. See more here
People with a worrying cough, problems swallowing or blood in their urine will soon be able to be referred for scans and checks by a pharmacist, rather than by their GP. A new pilot scheme, in England, aims to diagnose more cancers early, when there is a better chance of a cure. The NHS also plans to offer Jewish people genetic screening – as up to one in 40 has Brca mutations, linked to a higher risk of breast, ovarian and prostate cancers, compared with one in 400 in the general population.
Scientists say they have identified urine bacteria which are linked to aggressive PCa. The discovery might provide new ways to spot and even prevent these dangerous tumours, experts hope. See moreÂ And scientists have hypothesised that if they found a way to get zinc into malignant cells that might be helpful. More here
A new programme to close the gap for Black men with PCa was announced by Prostate Cancer Research in August. See more here And Participants aged 18+ are needed to examine how Black men use recorded music/song choices to process the impact of their PCa. The study also seeks to enable the future development of culturally appropriate peer support groups for psychosocial help using music. Tackle Director Alphonso Archer, a music therapy master’s student at the UWE, will conduct the research online. This should take about 60-90 minutes to complete in the form of a semi-structured interview. To find out more and to participate go here, And In partnership with Movember, Prostate Cancer UK is funding a study to help find out why Black men are at higher risk of PCa than other ethnic groups. More here Â And Prostate Cancer Research announced an initial Â£875k investment in finding answers to Black men’s higher risks of diagnosis and death. Black men are twice as likely to get PCa and 2.5 times more likely to die from it than White men. Five new projects launched to specifically tackle this inequity. More here
A hunt is on for 14,000 men who itâ€™s estimated havenâ€™t started PCa treatment due to the pandemic (Feb ’22). Men are asked to answer three quick questions at this risk checker: The â€˜Find the 14,000 menâ€™ campaign by Prostate Cancer UK has been nominated for the NHS Communinications Initiative of the Year Award at the 2022 Health Service Journal Awards (Aug ’22).
A new radiation treatment was approved by the US FDA in March for certain patients with advanced PCa. It has been shown to help patients with advanced PCa live longer and maintain quality of life (Mar â€™22). See more here
Ryan Edginton told us about the Raman Nanotheranostics (RaNT) team who are developing a new, all-in-one technology capable of diagnosing and treating cancers using a single device. See the video here